Nasus Pharma (NSRX) Stock: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.95
0.03 (0.86%)
▲
5d:
+10.13%
30d:
+5.43%
90d:
+29.63%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Jun 24, 2026
0d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NSRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NSRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.95, which is considered extended relative to its 30-day fair value range of $3.47 to $3.90.
Technical Outlook: Technically, NSRX is in a strong uptrend. Immediate support is located at $3.35, while resistance sits at $4.10.
Market Sentiment: NSRX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.67 (+401.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NSRX is in a strong uptrend. Immediate support is located at $3.35, while resistance sits at $4.10.
Market Sentiment: NSRX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.67 (+401.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.47 -
$3.90
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 401.7% below Wall St target ($19.67)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.47 -
$3.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.35
Resistance Level
$4.10
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.48
Wall Street Target
$19.67
(+401.7%)
Share & Embed Analysis
Last updated: October 05, 2026 12:07 PM ET
Data refreshes hourly during market hours. Next update: 1:07 PM
Data refreshes hourly during market hours. Next update: 1:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
30 analysts |
$279 | 60 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
30 analysts |
$1329 | 42 HOLD |
|
BIIB
Biogen Inc |
BUY
35 analysts |
$238 | 54 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
27 analysts |
$159 | 45 HOLD |
|
MRK
Merck & Company Inc |
STRONG BUY
27 analysts |
$156 | 50 HOLD |